The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
Open accessAbstract
Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans of all ages and can affect both pulmonary and extrapulmonary sites. This guideline focuses on pulmonary disease in adults (without cystic fibrosis or human immunodeficiency virus infection) caused by the most common NTM pathogens such as Mycobacterium avium complex,Mycobacterium kansasii, and Mycobacterium xenopi among the slowly growing NTM and Mycobacterium abscessus among the rapidly growing NTM. A panel of experts was carefully selected by leading international respiratory medicine and infectious diseases societies (ATS, ERS, ESCMID, IDSA) and included specialists in pulmonary medicine, infectious diseases and clinical microbiology, laboratory medicine, and patient advocacy. Systematic reviews were conducted around each of 22 PICO (Population, Intervention, Comparator, Outcome) questions and the recommendations were formulated, written, and graded using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach. Thirty-one evidence-based recommendations about treatment of NTM pulmonary disease are provided. This guideline is intended for use by healthcare professionals who care for patients with NTM pulmonary disease, including specialists in infectious diseases and pulmonary diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Self-citationGRADE guidelines: 2. Framing the question and deciding on important outcomes
Guyatt, G. H., Oxman, A. D., Kunz, R., Atkins, D., Brozek, J., Vist, G., Alderson, P., Glasziou, P., Falck-Ytter, Y., & Schünemann, H. J. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.012 · Cited by 1,911
Andrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K., Meerpohl, J. J., Coello, P. A., Rind, D., Montori, V. M., Brito, J. P., Norris, S., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,315
Self-citationNahid, P., Dorman, S. E., Alipanah, N., Barry, P. M., Brozek, J. L., Cattamanchi, A., Chaisson, L. H., Chaisson, R. E., Daley, C. L., Grzemska, M., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw376 · Cited by 1,170
Self-citationSusceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes
Woods, G. L., Brown‐Elliott, B. A., Conville, P. S., Desmond, E. P., Hall, G. S., Lin, G., Pfyffer, G. E., Ridderhof, J. C., Siddiqi, S. H., Wallace, R. J., et al. (2011) · Cited by 1,136
Self-citationEpidemiology of Human Pulmonary Infection with Nontuberculous Mycobacteria
Prevots, D. R., & Marras, T. K. (2015) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2014.10.002 · Cited by 920
Self-citationDiagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria
(1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.2.atsstatement · Cited by 790
Prevalence of Nontuberculous Mycobacterial Lung Disease in U.S. Medicare Beneficiaries
Adjemian, J., Olivier, K. N., Seitz, A. E., Holland, S. M., & Prevots, D. R. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2016oc · Cited by 690
Self-citationNash, K. A., Brown-Elliott, B. A., & Wallace, R. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01275-08 · Cited by 638
Self-citationNontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems
Prevots, D. R., Shaw, P. A., Strickland, D., Jackson, L. A., Raebel, M. A., Blosky, M. A., Montes de Oca, R., Shea, Y. R., Seitz, A. E., Holland, S. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201002-0310oc · Cited by 582
Self-citationSchünemann, H. J., Jaeschke, R., Cook, D. J., Bria, W. F., El-Solh, A. A., Ernst, A., Fahy, B. F., Gould, M. K., Horan, K. L., Krishnan, J. A., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-197st · Cited by 577
rpoB -Based Identification of Nonpigmented and Late-Pigmenting Rapidly Growing Mycobacteria
Adékambi, T., Colson, P., & Drancourt, M. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.12.5699-5708.2003 · Cited by 547
Brown-Elliott, B. A., Nash, K. A., & Wallace, R. J. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05030-11 · Cited by 541
Self-citationGriffith, D. E., Girard, W. M., & Wallace, R. J. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1271 · Cited by 518
Self-citationClinical Significance of Differentiation of Mycobacterium massiliense from Mycobacterium abscessus
Koh, W.-J., Jeon, K., Lee, N. Y., Kim, B.-J., Kook, Y.-H., Lee, S.-H., Park, Y. K., Kim, C. K., Shin, S. J., Huitt, G. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0395oc · Cited by 515
Self-citationJarand, J., Levin, A., Zhang, L., Huitt, G., Mitchell, J. D., & Daley, C. L. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq237 · Cited by 429
Self-citationRoth, A., Fischer, M., Hamid, M. E., Michalke, S., Ludwig, W., & Mauch, H. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.1.139-147.1998 · Cited by 360
Clinical and Molecular Analysis of Macrolide Resistance in Mycobacterium avium Complex Lung Disease
Griffith, D. E., Brown-Elliott, B. A., Langsjoen, B., Zhang, Y., Pan, X., Girard, W., Nelson, K., Caccitolo, J., Alvarez, J., Shepherd, S., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-450oc · Cited by 357
Self-citationGriffith, D. E., Eagle, G., Thomson, R., Aksamit, T. R., Hasegawa, N., Morimoto, K., Addrizzo-Harris, D. J., O’Donnell, A. E., Marras, T. K., Flume, P. A., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1318oc · Cited by 356
Self-citationResistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria
van Ingen, J., Boeree, M. J., van Soolingen, D., & Mouton, J. W. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.04.001 · Cited by 351
Self-citationMacrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease
Wallace, R. J., Brown-Elliott, B. A., McNulty, S., Philley, J. V., Killingley, J., Wilson, R. W., York, D. S., Shepherd, S., & Griffith, D. E. (2014) · Chest · doi:10.1378/chest.13-2538 · Cited by 350
Self-citationJeon, K., Kwon, O. J., Lee, N. Y., Kim, B.-J., Kook, Y.-H., Lee, S.-H., Park, Y. K., Kim, C. K., & Koh, W.-J. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0704oc · Cited by 336
Bastian, S., Veziris, N., Roux, A.-L., Brossier, F., Gaillard, J.-L., Jarlier, V., & Cambau, E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00861-10 · Cited by 333
Self-citationHavlir, D. V., Dubé, M. P., Sattler, F. R., Forthal, D. N., Kemper, C. A., Dunne, M. W., Parenti, D. M., Lavelle, J. P., White, A. C., Witt, M. D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608083350604 · Cited by 329
Shafran, S. D., Singer, J., Zarowny, D. P., Phillips, P., Salit, I., Walmsley, S. L., Fong, I. W., Gill, M. J., Rachlis, A. R., Lalonde, R. G., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608083350602 · Cited by 307
Mycobacterium avium complex Pulmonary Disease in Patients Without HIV Infection
Field, S. K., Fisher, D., & Cowie, R. L. (2004) · Chest · doi:10.1378/chest.126.2.566 · Cited by 306
Chaisson, R. E., Benson, C. A., Dube, M. P., Heifets, L. B., Korvick, J. A., Elkin, S., Smith, T., Craft, J. C., Sattler, F. R., & and AIDS Clinical Trials Group Protocol 157 Study Team. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-12-199412150-00001 · Cited by 302
Pierce, M., Crampton, S., Henry, D., Heifets, L., LaMarca, A., Montecalvo, M., Wormser, G. P., Jablonowski, H., Jemsek, J., Cynamon, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608083350603 · Cited by 294
Cruciani, M., Scarparo, C., Malena, M., Bosco, O., Serpelloni, G., & Mengoli, C. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.2321-2325.2004 · Cited by 291
Wallace, R. J., Meier, A., Brown, B. A., Zhang, Y., Sander, P., Onyi, G. O., & Böttger, E. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.7.1676 · Cited by 283
Self-citationPrognostic Factors of 634 HIV-Negative Patients with Mycobacterium avium Complex Lung Disease
Hayashi, M., Takayanagi, N., Kanauchi, T., Miyahara, Y., Yanagisawa, T., & Sugita, Y. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201107-1203oc · Cited by 279
Clinical features of disease caused by rapidly growing mycobacteria
De, G. (1993) · Medical Entomology and Zoology · Cited by 279
Aminoglycoside Toxicity: Daily versus Thrice-Weekly Dosing for Treatment of Mycobacterial Diseases
Peloquin, C. A., Berning, S. E., Nitta, A. T., Simone, P. M., Goble, M., Huitt, G. A., Iseman, M. D., Cook, J. L., & Curran-Everett, D. (2004) · Clinical Infectious Diseases · doi:10.1086/420742 · Cited by 270
Self-citationvan Ingen, J., Bendien, S. A., de Lange, W. C. M., Hoefsloot, W., Dekhuijzen, P. N. R., Boeree, M. J., & van Soolingen, D. (2009) · Thorax · doi:10.1136/thx.2008.110957 · Cited by 266
Self-citationvan Ingen, J., Aksamit, T., Andrejak, C., Böttger, E. C., Cambau, E., Daley, C. L., Griffith, D. E., Guglielmetti, L., Holland, S. M., Huitt, G. A., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00170-2018 · Cited by 264
Self-citationNontuberculous Pulmonary Mycobacteriosis in Denmark: Incidence and Prognostic Factors
Andréjak, C., Thomsen, V. Ø., Johansen, I. S., Riis, A., Benfield, T. L., Duhaut, P., Sørensen, H. T., Lescure, F.-X., & Thomsen, R. W. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0778oc · Cited by 261
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients.
Wallace, R. J., Brown, B. A., Griffith, D. E., Girard, W. M., & Murphy, D. T. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.6.8665032 · Cited by 258
Self-citationRandomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease
Olivier, K. N., Griffith, D. E., Eagle, G., McGinnis, J. P., Micioni, L., Liu, K., Daley, C. L., Winthrop, K. L., Ruoss, S., Addrizzo-Harris, D. J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0700oc · Cited by 254
Self-citationPrammananan, T., Sander, P., Brown, B. A., Frischkorn, K., Onyi, G. O., Zhang, Y., Böttger, E. C., & Wallace, Jr. (1998) · The Journal of Infectious Diseases · doi:10.1086/515328 · Cited by 241
Self-citationTortoli, E., Kohl, T. A., Brown-Elliott, B. A., Trovato, A., Leão, S. C., Garcia, M. J., Vasireddy, S., Turenne, C. Y., Griffith, D. E., Philley, J. V., et al. (2016) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijsem.0.001376 · Cited by 241
Self-citationCohn, D. L., Catlin, B. J., Peterson, K. L., Judson, F. N., & Sbarbaro, J. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-3-112-6-407 · Cited by 232
Kwak, N., Park, J., Kim, E., Lee, C.-H., Han, S. K., & Yim, J.-J. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix517 · Cited by 222
McNabb, A., Eisler, D., Adie, K., Amos, M., Rodrigues, M., Stephens, G., Black, W. A., & Isaac-Renton, J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.7.3000-3011.2004 · Cited by 220
Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype
Koh, W.-J., Moon, S. M., Kim, S.-Y., Woo, M.-A., Kim, S., Jhun, B. W., Park, H. Y., Jeon, K., Huh, H. J., Ki, C.-S., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02503-2016 · Cited by 217
Self-citationMycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease
Koh, W.-J., Jeong, B.-H., Kim, S.-Y., Jeon, K., Park, K. U., Jhun, B. W., Lee, H., Park, H. Y., Kim, D. H., Huh, H. J., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw724 · Cited by 212
Self-citationPulmonary Nontuberculous Mycobacterial Disease, Ontario, Canada, 1998–2010
Marras, T. K., Mendelson, D., Marchand-Austin, A., May, K., & Jamieson, F. B. (2013) · Emerging Infectious Diseases · doi:10.3201/eid1911.130737 · Cited by 210
Self-citationThe Pharmacokinetics and Pharmacodynamics of Pulmonary Mycobacterium avium Complex Disease Treatment
van Ingen, J., Egelund, E. F., Levin, A., Totten, S. E., Boeree, M. J., Mouton, J. W., Aarnoutse, R. E., Heifets, L. B., Peloquin, C. A., & Daley, C. L. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0682oc · Cited by 202
Self-citationMeier, A., Kirschner, P., Springer, B., Steingrube, V. A., Brown, B. A., Wallace, R. J., & Böttger, E. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.2.381 · Cited by 195
Self-citationHuang, J. H., Kao, P. N., Adi, V., & Ruoss, S. J. (1999) · Chest · doi:10.1378/chest.115.4.1033 · Cited by 195
Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course
Hwang, J. A., Kim, S., Jo, K.-W., & Shim, T. S. (2017) · European Respiratory Journal · doi:10.1183/13993003.00537-2016 · Cited by 195
Choi, G.-E., Shin, S. J., Won, C.-J., Min, K.-N., Oh, T., Hahn, M.-Y., Lee, K., Lee, S. H., Daley, C. L., Kim, S., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2005oc · Cited by 194
Self-citationInitial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease.
Wallace, R. J., Brown, B. A., Griffith, D. E., Girard, W. M., Murphy, D. T., Onyi, G. O., Steingrube, V. A., & Mazurek, G. H. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.5.8173775 · Cited by 192
Self-citationHuman Infection with Atypical Acid-Fast Organisms: Report of Two Cases with Pathologic Findings
Buhler, V. B., & Pollak, A. (1953) · American Journal of Clinical Pathology · doi:10.1093/ajcp/23.4.363 · Cited by 190
Effect of Clarithromycin Regimen for Mycobacterium avium Complex Pulmonary Disease
TANAKA, E., KIMOTO, T., TSUYUGUCHI, K., WATANABE, I., MATSUMOTO, H., NIIMI, A., SUZUKI, K., MURAYAMA, T., AMITANI, R., & KUZE, F. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9811086 · Cited by 189
Factors Related to Response to Intermittent Treatment of Mycobacterium avium Complex Lung Disease
Lam, P. K., Griffith, D. E., Aksamit, T. R., Ruoss, S. J., Garay, S. M., Daley, C. L., & Catanzaro, A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1531oc · Cited by 187
Self-citationDiel, R., Ringshausen, F., Richter, E., Welker, L., Schmitz, J., & Nienhaus, A. (2017) · Chest · doi:10.1016/j.chest.2017.04.166 · Cited by 182
Inhaled Amikacin for Treatment of Refractory Pulmonary Nontuberculous Mycobacterial Disease
Olivier, K. N., Shaw, P. A., Glaser, T. S., Bhattacharyya, D., Fleshner, M., Brewer, C. C., Zalewski, C. K., Folio, L. R., Siegelman, J. R., Shallom, S., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201307-231oc · Cited by 176
Self-citationHarada, T., Akiyama, Y., Kurashima, A., Nagai, H., Tsuyuguchi, K., Fujii, T., Yano, S., Shigeto, E., Kuraoka, T., Kajiki, A., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01175-12 · Cited by 176
Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012
Henkle, E., Hedberg, K., Schafer, S., Novosad, S., & Winthrop, K. L. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201412-559oc · Cited by 175
Self-citationBrown-Elliott, B. A., Iakhiaeva, E., Griffith, D. E., Woods, G. L., Stout, J. E., Wolfe, C. R., Turenne, C. Y., & Wallace, R. J. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01612-13 · Cited by 173
Self-citationvan Ingen, J., Totten, S. E., Helstrom, N. K., Heifets, L. B., Boeree, M. J., & Daley, C. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01505-12 · Cited by 172
Self-citationMicrobiologic Outcome of Interventions Against Mycobacterium avium Complex Pulmonary Disease
Diel, R., Nienhaus, A., Ringshausen, F. C., Richter, E., Welte, T., Rabe, K. F., & Loddenkemper, R. (2018) · Chest · doi:10.1016/j.chest.2018.01.024 · Cited by 172
Tanaka, E., Amitani, R., Niimi, A., Suzuki, K., Murayama, T., & Kuze, F. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.6.9196113 · Cited by 168
Pasipanodya, J. G., Ogbonna, D., Ferro, B. E., Magombedze, G., Srivastava, S., Deshpande, D., & Gumbo, T. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01206-17 · Cited by 167
Kobashi, Y., Matsushima, T., & Oka, M. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2006.04.002 · Cited by 164
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases
Morimoto, K., Namkoong, H., Hasegawa, N., Nakagawa, T., Morino, E., Shiraishi, Y., Ogawa, K., Izumi, K., Takasaki, J., Yoshiyama, T., et al. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201604-246oc · Cited by 160
Griffith, D. E., Brown, B. A., Girard, W. M., & Wallace, R. J. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.3.594 · Cited by 159
Self-citationIntermittent Antibiotic Therapy for Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease
Jeong, B., Jeon, K., Park, H. Y., Kim, S., Lee, K. S., Huh, H. J., Ki, C., Lee, N. Y., Shin, S. J., Daley, C. L., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201408-1545oc · Cited by 156
Self-citationResearch Committee of the British Thoracic Society (2001) · Thorax · doi:10.1136/thorax.56.3.167 · Cited by 153
Field, S. K., & Cowie, R. L. (2003) · CHEST Journal · doi:10.1378/chest.124.4.1482 · Cited by 147
Jarand, J. M., Davis, J. P., Cowie, R. L., Field, S. K., & Fisher, D. A. (2015) · CHEST Journal · doi:10.1378/chest.15-0543 · Cited by 147
Adverse events in people taking macrolide antibiotics versus placebo for any indication
Hansen, M. P., Scott, A. M., McCullough, A. R., Thorning, S., Aronson, J. K., Beller, E., Glasziou, P., Hoffmann, T., Clark, J. M., & Mar, C. D. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011825.pub2 · Cited by 145
Gordin, F. M., Sullam, P. M., Shafran, S. D., Cohn, D. L., Wynne, B. A., Paxton, L., Perry, K., & Horsburgh, C. R. (1999) · Clinical Infectious Diseases · doi:10.1086/514748 · Cited by 144
Moon, S. M., Park, H. Y., Kim, S., Jhun, B. W., Lee, H. J., Jeon, K., Kim, D. H., Huh, H. J., Ki, C., Lee, N. Y., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01240-16 · Cited by 143
Self-citationPark, J., Cho, J., Lee, C., Han, S. K., & Yim, J. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw723 · Cited by 143
Benson, C. A., Williams, P. L., Currier, J. S., Holland, F., Mahon, L. F., MacGregor, R. R., Inderlied, C. B., Flexner, C. W., Neidig, J. L., Chaisson, R. E., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/378807 · Cited by 142
Macrolide antibiotics for bronchiectasis
Kelly, C. A., Chalmers, J. D., Crossingham, I. R., Relph, N., Felix, L. M., Evans, D. J., Milan, S. J., & Spencer, S. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012406.pub2 · Cited by 141
How to: identify non-tuberculous Mycobacterium species using MALDI-TOF mass spectrometry
Alcaide, F., Amlerová, J., Bou, G., Ceyssens, P. J., Coll, P., Corcoran, D., Fangous, M.-S., González-Álvarez, I., Gorton, R., Greub, G., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.11.012 · Cited by 138
Self-citationSchembri, S., Williamson, P. A., Short, P. M., Singanayagam, A., Akram, A. R., Taylor, J., Singanayagam, A., Hill, A. T., & Chalmers, J. D. (2013) · BMJ · doi:10.1136/bmj.f1235 · Cited by 135
A definition of the Mycobacterium avium complex for taxonomical and clinical purposes, a review
van Ingen, J., Turenne, C. Y., Tortoli, E., Wallace, R. J., & Brown‐Elliott, B. A. (2018) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijsem.0.003026 · Cited by 135
Self-citationMiwa, S., Shirai, M., Toyoshima, M., Shirai, T., Yasuda, K., Yokomura, K., Yamada, T., Masuda, M., Inui, N., Chida, K., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201308-266oc · Cited by 132
Ethambutol Ocular Toxicity in Treatment Regimens for Mycobacterium avium Complex Lung Disease
Griffith, D. E., Brown‐Elliott, B. A., Shepherd, S., McLarty, J. W., Griffith, L., & Wallace, R. J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-863oc · Cited by 126
Self-citationBrown, B. A., Wallace, R. J., & Onyi, G. O. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.1987 · Cited by 124
Self-citationMaurer, F. P., Rüegger, V. L., Ritter, C., Bloemberg, G. V., & Böttger, E. C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks279 · Cited by 124
Self-citationComparative safety of the different macrolides
Rubinstein, E. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00397-1 · Cited by 121
Anatomic Lung Resection for Nontuberculous Mycobacterial Disease
Mitchell, J. D., Bishop, A., Cafaro, A., Weyant, M. J., & Pomerantz, M. (2008) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2008.02.041 · Cited by 120
Lee, G., Lee, K. S., Moon, J. W., Koh, W., Jeong, B., Jeong, Y. J., Kim, H. J., & Woo, S. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201303-062oc · Cited by 120
Drug intolerance to high-dose clarithromycin among elderly patients
Wallace, R. J., Brown, B. A., & Griffith, D. E. (1993) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(93)90112-k · Cited by 119
Self-citationAlcaide, F., Benítez, M. Á., Escribà, J. M., et al. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.1.398-401.2000 · Cited by 119
Meier, A., Heifets, L. B., Wallace, R. J., Zhang, Y., Brown, B. A., Sander, P., & Böttger, E. C. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.2.354 · Cited by 117
Self-citationGriffith, D. E., Brown, B. A., Cegielski, P., Murphy, D. T., & Wallace, R. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313644 · Cited by 116
Self-citationRifampin-Resistant Mycobacterium kansasii
Wallace, R. J., Dunbar, D., Brown, B. A., Onyi, G. O., Dunlap, R., Ahn, C. H., & Murphy, D. T. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.5.736 · Cited by 115
Self-citationLyu, J., Jang, H. J., Song, J. W., Choi, C., Oh, Y., Lee, S., Kim, W. S., Kim, D. S., & Shim, T. S. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2010.12.012 · Cited by 115
Gochi, M., Takayanagi, N., Kanauchi, T., Ishiguro, T., Yanagisawa, T., & Sugita, Y. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008058 · Cited by 115
Ferro, B. E., Meletiadis, J., Wattenberg, M., de Jong, A., van Soolingen, D., Mouton, J. W., & van Ingen, J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02615-15 · Cited by 115
Azithromycin-Containing Regimens for Treatment of Mycobacterium avium Complex Lung Disease
Griffith, D. E., Brown, B. A., Girard, W. M., Griffith, B. E., Couch, L., & Wallace, R. J. (2001) · Clinical Infectious Diseases · doi:10.1086/320512 · Cited by 113
Self-citationWallace, R. J., Zhang, Y., Brown‐Elliott, B. A., Yakrus, M. A., Wilson, R. W., Mann, L. B., Couch, L., Girard, W. M., & Griffith, D. E. (2002) · The Journal of Infectious Diseases · doi:10.1086/341207 · Cited by 111
Self-citationTreatment ofMycobacterium abscessusInfection
Novosad, S., Beekmann, S. E., Polgreen, P. M., Mackey, K., Winthrop, K. L., & M. abscessus Study Team (2016) · Emerging infectious diseases · doi:10.3201/eid2203.150828 · Cited by 111
Self-citationGriffith, D. E., Brown‐Elliott, B. A., & Wallace, R. J. (2003) · Clinical Infectious Diseases · doi:10.1086/378742 · Cited by 108
Self-citationTortoli, E., Pecorari, M., Fabio, G., Messinò, M., & Fabio, A. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01536-09 · Cited by 108
Self-citationRoux, A., Catherinot, É., Soismier, N., Heym, B., Bellis, G., Lemonnier, L., Chiron, R., Fauroux, B., Bourgeois, M. L., Munck, À., et al. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.07.004 · Cited by 104
Self-citationTuberculosis pharmacotherapy: strategies to optimize patient care
Mitnick, C. D., McGee, B., & Peloquin, C. A. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802694564 · Cited by 103
Kobashi, Y., Yoshida, K., Miyashita, N., Niki, Y., & Oka, M. (2006) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-006-0457-8 · Cited by 101
Griffith, D. E., Brown, B. A., Girard, W. M., Murphy, D. T., & Wallace, R. J. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.5.983 · Cited by 101
Self-citationImpaired health-related quality of life in pulmonary nontuberculous mycobacterial disease
Mehta, M., & Marras, T. K. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.08.004 · Cited by 100
Self-citationAndréjak, C., Lescure, F. X., Pukenytė, E., Douadi, Y., Yazdanpanah, Y., Laurans, G., Schmit, J. L., Jounieaux, V., & and the Xenopi Group (2008) · Thorax · doi:10.1136/thx.2008.096842 · Cited by 99
Clinical Outcome of Mycobacterium abscessus Infection and Antimicrobial Susceptibility Testing
Huang, Y., Liu, M.-F., Shen, G., Lin, C.-F., Kao, C.-C., Liu, P., & Shi, Z. (2010) · Journal of Microbiology Immunology and Infection · doi:10.1016/s1684-1182(10)60063-1 · Cited by 98
Pasipanodya, J. G., Ogbonna, D., Deshpande, D., Srivastava, S., & Gumbo, T. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx311 · Cited by 94
Results of operation in Mycobacterium avium-intracellulare lung disease
Nelson, K. G., Griffith, D. E., Brown, B. A., & Wallace, R. J. (1998) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(98)00401-9 · Cited by 93
Self-citationInteraction between midazolam and clarithromycin: comparison with azithromycin.
Yeates, R. A., Laufen, H., & Zimmermann, T. (1996) · PubMed · Cited by 91
Treatment of Slowly Growing Mycobacteria
Philley, J. V., & Griffith, D. E. (2014) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2014.10.005 · Cited by 87
Self-citationYu, J. A., Pomerantz, M., Bishop, A., Weyant, M. J., & Mitchell, J. D. (2011) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2010.12.028 · Cited by 87
Pulmonary Nontuberculous Mycobacteria–Associated Deaths, Ontario, Canada, 2001–2013
Marras, T. K., Campitelli, M. A., Lu, H., Chung, H., Brode, S. K., Marchand‐Austin, A., Winthrop, K. L., Gershon, A. S., Kwong, J. C., & Jamieson, F. (2017) · Emerging infectious diseases · doi:10.3201/eid2303.161927 · Cited by 87
Self-citationTherapeutic Drug Monitoring in the Treatment of Mycobacterium avium Complex Lung Disease
Koh, W., Jeong, B., Jeon, K., Lee, S., & Shin, S. J. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201206-1088oc · Cited by 86
Treatment of Pulmonary Disease Due to Mycobacterium kansasii: Recent Experience with Rifampin
Pezzia, W., Raleigh, J. W., Bailey, M. C., Toth, E. A., & Silverblatt, J. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.5.1035 · Cited by 85
Pneumonectomy for nontuberculous mycobacterial infections
Shiraishi, Y., Nakajima, Y., Katsuragi, N., Kurai, M., & Takahashi, N. (2004) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2004.02.103 · Cited by 84
Utility of rpoB Gene Sequencing for Identification of Nontuberculous Mycobacteria in the Netherlands
de Zwaan, R., van Ingen, J., & van Soolingen, D. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00233-14 · Cited by 81
Semiquantitative Culture Analysis during Therapy for Mycobacterium avium Complex Lung Disease
Griffith, D. E., Adjemian, J., Brown‐Elliott, B. A., Philley, J. V., Prevots, D. R., Gaston, C., Olivier, K. N., & Wallace, R. J. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201503-0444oc · Cited by 81
Self-citationSurgery for Mycobacterium avium complex lung disease in the clarithromycin era
Shiraishi, Y., Nakajima, Y., Takasuna, K., Hanaoka, T., Katsuragi, N., & Konno, H. (2002) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(01)01122-8 · Cited by 81
Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii.
Ahn, C. H., Lowell, J. R., Ahn, S. S., Ahn, S. I., & Hurst, G. A. (1983) · PubMed · doi:10.1164/arrd.1983.128.6.1048 · Cited by 81
Treatment outcomes of adjuvant resectional surgery for nontuberculous mycobacterial lung disease
Kang, H. K., Park, H. Y., Kim, D., Jeong, B., Jeon, K., Cho, J. H., Kim, H. K., Choi, Y. S., Kim, J., & Koh, W. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0823-1 · Cited by 80
Buchan, B. W., Riebe, K. M., Timke, M., Kostrzewa, M., & Ledeboer, N. A. (2013) · American Journal of Clinical Pathology · doi:10.1309/ajcpbpubudew2oag · Cited by 80
Henkle, E. M., Aksamit, T. R., BARKER, A. R., Daley, C. L., Griffith, D. E., Leitman, P., Leitman, A., Malanga, E., Marras, T. K., Olivier, K. N., et al. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201605-387ws · Cited by 78
Self-citationIdígoras, P., Beristaín, X., Iturzaeta, A., et al. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050492 · Cited by 76
Lu, D., Heeren, B., & Dunne, W. M. (2002) · American Journal of Clinical Pathology · doi:10.1309/65kn-2m7e-7mnn-x0ta · Cited by 76
Brown, B. A., Griffith, D. E., Girard, W., Levin, J., & Wallace, R. J. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.5.958 · Cited by 74
Self-citationSelection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies
Mougari, F., Bouziane, F., Crockett, F., Nessar, R., Chau, F., Véziris, N., Sapriel, G., Raskine, L., & Cambau, E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00943-16 · Cited by 74
Self-citationMycobacterium avium complex infection in non‐cystic fibrosis bronchiectasis
Zoumot, Z., Boutou, A., Gill, S. S., van Zeller, M., Hansell, D. M., Wells, A. U., Wilson, R., & Loebinger, M. R. (2014) · Respirology · doi:10.1111/resp.12287 · Cited by 73
Clinical relevance of Mycobacterium chelonae–abscessus group isolation in 95 patients
van Ingen, J., de Zwaan, R., Dekhuijzen, R. P. N., Boeree, M. J., & van Soolingen, D. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.08.016 · Cited by 72
Lyu, J., Kim, B., Kim, B.-J., Song, J. W., Choi, C., Oh, Y., Lee, S., Kim, W. S., Kim, D. S., & Shim, T. S. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.09.002 · Cited by 72
Griffith, D. E., Brown, B. A., Murphy, D. T., Girard, W. M., Couch, L., & Wallace, R. J. (1998) · The Journal of Infectious Diseases · doi:10.1086/515597 · Cited by 72
Self-citationJeong, B., Jeon, K., Park, H. Y., Moon, S. M., Kim, S., Lee, S., Shin, S. J., Daley, C. L., & Koh, W. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00770-16 · Cited by 67
Self-citationAhn, C. H., Lowell, J. R., Ahn, S. S., Ahn, S. S., & Hurst, G. A. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.5.1028 · Cited by 66
Jenkins, P., & CAMPBELL, I. A. (2003) · Respiratory Medicine · doi:10.1053/rmed.2002.1444 · Cited by 64
Daniel-Wayman, S., Abate, G., Barber, D. L., Bermudez, L. E., Coler, R. N., Cynamon, M. H., Daley, C. L., Davidson, R. M., Dick, T., Floto, R. A., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1273pp · Cited by 64
Self-citationYagi, K., Ishii, M., Namkoong, H., Asami, T., Iketani, O., Asakura, T., Suzuki, S., Sugiura, H., Yamada, Y., Nishimura, T., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2665-5 · Cited by 62
Gluud, C. N., Als-Nielsen, B. E. T., Damgaard, M., Hansen, J. F., Hansen, S., Helø, O. H., Hildebrandt, P. R., Hilden, J., Jensen, G. B., Kastrup, J., et al. (2008) · Cardiology · doi:10.1159/000128994 · Cited by 61
Mougari, F., Amarsy, R., Véziris, N., Bastian, S., Brossier, F., Berçot, B., Raskine, L., & Cambau, E. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw130 · Cited by 59
Self-citationKoh, W., Jeong, B., Jeon, K., Kim, S., Park, K. U., Park, H. Y., Huh, H. J., Ki, C., Lee, N. Y., Lee, S., et al. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.05.003 · Cited by 59
Self-citationSulfonamide-containing regimens for disease caused by rifampin-resistant Mycobacterium kansasii.
Ahn, C. H., Wallace, R. J., Steele, L. C., & Murphy, D. T. (1987) · PubMed · doi:10.1164/arrd.1987.135.1.10 · Cited by 58
Self-citationThe TAMI Group, Shu, C., Lee, C., Hsu, C., Wang, J., Wang, J.-Y., Yu, C., & Lee, L. (2011) · Lung · doi:10.1007/s00408-011-9321-4 · Cited by 57
Sugihara, E., Hirota, N., Niizeki, T., Tanaka, R., Nagafuchi, M., Koyanagi, T., Ono, N., Sugihara, E., Tanaka, R., Nagafuchi, M., et al. (2003) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-003-0267-1 · Cited by 57
Diagnosis of Disease Caused by Mycobacterium avium Complex*
Tsukamura, M. (1991) · CHEST Journal · doi:10.1378/chest.99.3.667 · Cited by 57
Czaja, C. A., Levin, A. R., Cox, C. W., Vargas, D., Daley, C. L., & Cott, G. R. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201508-529oc · Cited by 57
Self-citationSurgical Treatment of Pulmonary Diseases Due to Nontuberculous Mycobacteria
Koh, W., Kim, Y. H., Kwon, O. J., Choi, Y. S., Kim, K., Shim, Y. M., & Kim, J. (2008) · Journal of Korean Medical Science · doi:10.3346/jkms.2008.23.3.397 · Cited by 55
HUMAN INFECTION WITH ATYPICAL ACID-FAST ORGANISMS
Buhler, V. B., & Pollack, A. (1953) · Cited by 55
Zweijpfenning, S. M. H., Kops, S. E. P., Magis-Escurra, C., Boeree, M. J., van Ingen, J., & Hoefsloot, W. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.08.031 · Cited by 55
Sauret, J., Hernández-Flix, S., Castro, E., Hernández, L., Ausina, V., & Coll, P. (1995) · Tubercle and Lung Disease · doi:10.1016/0962-8479(95)90550-2 · Cited by 54
Early pulmonary resection for localized mycobacterium avium complex disease
Shiraishi, Y., Fukushima, K., Komatsu, H., & Kurashima, A. (1998) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(98)00373-7 · Cited by 53
Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease
Jhun, B. W., Yang, B., Moon, S. M., Lee, H. J., Park, H. Y., Jeon, K., Kwon, O. J., Ahn, J., Moon, I. J., Shin, S. J., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00011-18 · Cited by 53
Self-citationLong-term relapses after 12-month treatment forMycobacterium kansasiilung disease
Santín, M., Dorca, J., Alcaide, F., Gonzalez, L. C., Casas, S., Lopez, M., & Guerra, M. (2008) · European Respiratory Journal · doi:10.1183/09031936.00024008 · Cited by 50
Gommans, E. P. A. T., Even, P., Linssen, C. F. M., van Dessel, H. A., van Haren, E., de Vries, G. J., Dingemans, A. C., Kotz, D., & Rohde, G. G. U. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.10.013 · Cited by 49
Kobashi, Y., Abe, M., Mouri, K., Obase, Y., Kato, S., & Oka, M. (2011) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-011-0351-x · Cited by 48
Griffith, D. E., Philley, J. V., Brown‐Elliott, B. A., Benwill, J. L., Shepherd, S., York, D., & Wallace, R. J. (2014) · CHEST Journal · doi:10.1378/chest.14-1297 · Cited by 47
Self-citationDrug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii
Bakuła, Z., Modrzejewska, M., Pennings, L. J., Proboszcz, M., Safianowska, A., Bielecki, J., van Ingen, J., & Jagielski, T. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01788-17 · Cited by 47
Makek, M. J., Sabol, I., Žmak, L., et al. (2016) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.15.0633 · Cited by 45
Leyer, C., Gregorowicz, G., Mougari, F., Raskine, L., Cambau, E., & Briel, D. D. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00006-17 · Cited by 45
Self-citationvan Ingen, J., Boeree, M. J., van Soolingen, D., Iseman, M. D., Heifets, L. B., & Daley, C. L. (2011) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2011.10.006 · Cited by 44
Self-citationGuna, R., Muñoz, C., Domínguez, V., García-García, Á., Gálvez, J., de Julián‐Ortiz, J. V., & Borrás, R. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki111 · Cited by 43
Deggim, V., Bloemberg, G. V., Ritter, C., Voit, A., Hömke, R., Keller, P. M., & Böttger, E. C. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.06.016 · Cited by 43
Self-citationChoi, H., Kim, S., Lee, H. J., Jhun, B. W., Park, H. Y., Jeon, K., Kim, D. H., Huh, H. J., Ki, C., Lee, N. Y., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02189-16 · Cited by 39
Self-citationvan Eck, K., Faro, D., Wattenberg, M., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00304-16 · Cited by 37
The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease
Fujita, M., Ouchi, H., Harada, E., Ikegame, S., Nakanishi, Y., Fujita, M., Matsumoto, T., Uchino, J., Watanabe, K., Kajiki, A., et al. (2011) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-011-0303-5 · Cited by 31
Time–kill kinetics of slowly growing mycobacteria common in pulmonary disease
Ferro, B. E., van Ingen, J., Wattenberg, M., van Soolingen, D., & Mouton, J. W. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv180 · Cited by 30
van Ingen, J., Hoefsloot, W., Mouton, J. W., et al. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.03.010 · Cited by 28
Concomitant Use of Voriconazole and Rifabutin in a Patient with Multiple Infections
Schwiesow, J. N., Iseman, M. D., & Peloquin, C. A. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.8.1076 · Cited by 28
Wang, D., Fu, W., & Dai, J. (2019) · Medicine · doi:10.1097/md.0000000000015285 · Cited by 28
Andréjak, C., Almeida, D. V., Tyagi, S. K., Converse, P. J., Ammerman, N. C., & Grosset, J. H. E. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks421 · Cited by 27
Treatment of Pulmonary Nontuberculous Mycobacterial Infections: Many Questions Remain
Daley, C. L., & Glassroth, J. L. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201311-399ed · Cited by 17
Self-citationHong, J. Y., Lee, S. A., Kim, S. Y., Chung, K. S., Moon, S. W., Kim, E. Y., Jung, J. Y., Park, M. S., Kim, Y. S., Kim, S. I., et al. (2014) · Quality of Life Research · doi:10.1007/s11136-014-0727-3 · Cited by 14
Cited by
Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review
Dahl, V. N., Mølhave, M., Fløe, A., van Ingen, J., Schön, T., Lillebaek, T., Andersen, A. B., & Wejse, C. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.10.013 · Cited by 329
Self-citationTo, K., Cao, R., Yegiazaryan, A., Owens, J., & Venketaraman, V. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082541 · Cited by 264
Metadata
- Authors
- Daley, C. L., Iaccarino, J. M., Lange, C., Cambau, E., Wallace, R. J., Andrejak, C., Böttger, E. C., Brozek, J., Griffith, D. E., Guglielmetti, L., Huitt, G. A., Knight, S. L., Leitman, P., Marras, T. K., Olivier, K. N., Santin, M., Stout, J. E., Tortoli, E., van Ingen, J., Wagner, D., & Winthrop, K. L.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2020-07
- Volume
- 56
- Issue
- 1
- Pages
- 2000535
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W3038927358
- Cited by
- 924
- References
- 173
- FWCI
- 56.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.